Physician profile
Kimberly Phan
NPI 1912566910
$1,520.48
in general payments reported to CMS, 2019-2025
15 companies · $552 in 2025
The $552 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.53 · 2022: $185 · 2023: $202 · 2024: $551 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,304.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $327.44 | 2022-2025 | Wegovy, Saxenda, Ozempic |
| Lilly USA, LLC | $267.35 | 2023-2025 | Zepbound, Mounjaro |
| Viiv Healthcare Company | $258.88 | 2023-2024 | Dovato |
| Abbvie INC. | $164.64 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $122.13 | 2023 | Sotyktu |
| Amgen INC. | $82.39 | 2025 | Otezla, Prolia, Evenity |
| Glaxosmithkline, LLC. | $60.97 | 2021-2025 | Bexsero |
| Genzyme Corporation | $55.57 | 2023-2024 | |
| Pfizer INC. | $37.47 | 2022 | |
| Novartis Pharmaceuticals Corporation | $35.50 | 2025 | |
| Astellas Pharma US INC | $31.44 | 2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $23.13 | 2025 | Breztri |
| Ucb, INC. | $21.25 | 2024 | Bimzelx |
| Abbott Laboratories | $17.73 | 2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $14.59 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.